Management of non-alcoholic fatty liver disease in 2015 (Q26771148)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Management of non-alcoholic fatty liver disease in 2015	scientific article

Statements

instance of

scholarly article

0 references

title

Management of non-alcoholic fatty liver disease in 2015 (English)

0 references

main subject

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

liver disease

1 reference

based on heuristic

inferred from title

author name string

Neel Malhotra

series ordinal

1

0 references

Melanie D Beaton

series ordinal

2

0 references

language of work or name

English

0 references

publication date

28 December 2015

0 references

published in

World Journal of Hepatology

1 reference

stated in

Crossref

volume

7

0 references

issue

30

0 references

page(s)

2962-7

0 references

cites work

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

7 April 2017

Microbial ecology: human gut microbes associated with obesity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

7 April 2017

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

7 April 2017

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

7 April 2017

Microbiota and SCFA in lean and overweight healthy subjects

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

7 April 2017

Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Gut microbiome and nonalcoholic fatty liver diseases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Recent advances in the herbal treatment of non-alcoholic Fatty liver disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Is it time to write a prescription for coffee? Coffee and liver disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Dietary fructose in nonalcoholic fatty liver disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Implications of diet on nonalcoholic fatty liver disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Saturated fatty acids and insulin resistance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

The human gut microbiome: implications for future health care

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Liver fibrosis: a balance of ACEs?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691699

retrieved

28 September 2017

Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4254%2FWJH.V7.I30.2962

retrieved

21 January 2018

No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4254%2FWJH.V7.I30.2962

retrieved

21 January 2018

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4254%2FWJH.V7.I30.2962

retrieved

21 January 2018

Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4254%2FWJH.V7.I30.2962

retrieved

21 January 2018

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4254%2FWJH.V7.I30.2962

retrieved

21 January 2018

Gut microbiome-host interactions in health and disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4254%2FWJH.V7.I30.2962

retrieved

21 January 2018

Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26730275

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26730275

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.4254/WJH.V7.I30.2962

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3833975

OpenCitations bibliographic resource ID

3833975

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3833975

PMC publication ID

4691699

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3833975

PubMed publication ID

26730275

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3833975

ResearchGate publication ID

288479996

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26771148&oldid=1531445324"